Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Mauriello, J A
and
Aljian, J
1991.
Natural history of treatment of facial dyskinesias with botulinum toxin: a study of 50 consecutive patients over seven years..
British Journal of Ophthalmology,
Vol. 75,
Issue. 12,
p.
737.
Oates, John A.
Wood, Alastair J.J.
Jankovic, Joseph
and
Brin, Mitchell F.
1991.
Therapeutic Uses of Botulinum Toxin.
New England Journal of Medicine,
Vol. 324,
Issue. 17,
p.
1186.
Tim, Richard
and
Massey, Janice M.
1992.
Botulinum toxin therapy for neurologic disorders.
Postgraduate Medicine,
Vol. 91,
Issue. 6,
p.
327.
Yoshimura, Don M.
Aminoff, Michael J.
Tami, Thomas A.
and
Scott, Alan B.
1992.
Treatment of hemifacial spasm with botulinum toxin.
Muscle & Nerve,
Vol. 15,
Issue. 9,
p.
1045.
Brin, Mitchell F.
Blitzer, Andrew
Stewart, Celia
Pine, Zachary
Borg-Stein, Joanne
Miller, James
Viswanath, Nagalapura S.
and
Rosenfield, David B.
1993.
Botulinum and Tetanus Neurotoxins.
p.
559.
Robinson, Lawrence R.
and
Hillel, Allen D.
1993.
Botulinum Toxin Treatment for Motor Control Disorders.
Physical Medicine and Rehabilitation Clinics of North America,
Vol. 4,
Issue. 4,
p.
731.
Cardoso, F.
and
Jankovic, J.
1995.
Clostridial Neurotoxins.
Vol. 195,
Issue. ,
p.
123.
Cichon, John V.
Mccaffrey, Thomas V.
Litchy, William J.
and
Knops, Joost L.
1995.
The effect of botulinum toxin type a injection on compound muscle action potential in an in vivo rat model.
The Laryngoscope,
Vol. 105,
Issue. 2,
p.
144.
Ainsworth, John R.
and
Kraft, Stephen P.
1995.
Long-term Changes in Duration of Relief with Botulinum Toxin Treatment of Essential Blepharospasm and Hemifacial Spasm.
Ophthalmology,
Vol. 102,
Issue. 12,
p.
2036.
Chen, R.-S.
Lu, C.-S.
and
Tsai, C.-H.
1996.
Botulinum toxin A injection in the treatment of hemifacial spasm.
Acta Neurologica Scandinavica,
Vol. 94,
Issue. 3,
p.
207.
Mauriello, Joseph A.
Leone, Tina
Dhillon, Shamina
Pakeman, Basil
Mostafavi, Ramin
and
Yepez, Maria C.
1996.
Treatment choices of 119 patients with hemifacial spasm over 11 years.
Clinical Neurology and Neurosurgery,
Vol. 98,
Issue. 3,
p.
213.
Dutton, Jonathan J.
1996.
Botulinum-A toxin in the treatment of craniocervical muscle spasms: Short- and long-term, local and systemic effects.
Survey of Ophthalmology,
Vol. 41,
Issue. 1,
p.
51.
Carruthers, Alastair
Kiene, Kevin
and
Carruthers, Jean
1996.
Botulinum A exotoxin use in clinical dermatology.
Journal of the American Academy of Dermatology,
Vol. 34,
Issue. 5,
p.
788.
Dodd, S.L.
Rowell, B.A.
Vrabas, I.S.
Arrowsmith, R.J.
and
Weatherill, P.J.
1998.
A comparison of the spread of three formulations of botulinum neurotoxin A as determined by effects on muscle function.
European Journal of Neurology,
Vol. 5,
Issue. 2,
p.
181.
Benedetto, Anthony V.
and
Do, .
1999.
The cosmetic uses of Botulinum toxin type A.
International Journal of Dermatology,
Vol. 38,
Issue. 9,
p.
641.
Dejonckere, P.H.O.
1999.
Handboek Stem– Spraak– Taalpathologie.
p.
563.
Mahant, N.
Clouston, P.D.
and
Lorentz, I.T.
2000.
The current use of botulinum toxin.
Journal of Clinical Neuroscience,
Vol. 7,
Issue. 5,
p.
389.
Bell, Mark S.
Vermeulen, Lee C.
and
Sperling, Keith B.
2000.
Pharmacotherapy with Botulinum Toxin: Harnessing Nature's Most Potent Neurotoxin.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 20,
Issue. 9,
p.
1079.
Drummond, Garry T.
and
Hinz, Brad J.
2001.
Botulinum toxin for blepharospasm and hemifacial spasm: stability of duration of effect and dosage over time.
Canadian Journal of Ophthalmology,
Vol. 36,
Issue. 7,
p.
398.
Snir, Moshe
Weinberger, Dov
Bourla, Dan
Kristal-Shalit, Orhit
Dotan, Gad
and
Axer-Siegel, Ruth
2003.
Quantitative changes in botulinum toxin a treatment over time in patients with essential blepharospasm and idiopathic hemifacial spasm.
American Journal of Ophthalmology,
Vol. 136,
Issue. 1,
p.
99.